source
- FDA to discontinue pilot program aimed at preventing drug production issuesThe U.S. Food and Drug Administration announced it will end a pilot program that was created to help drug manufacturers address production problems before they arise. The initiative, which ran for…
- FDA approves Nuvalent lung cancer drug shortly after GSK completes $10.6 billion acquisitionThe FDA announced Wednesday that it has approved a lung cancer medicine from Nuvalent, marking a key regulatory milestone for the biotech. The clearance arrived just a week after GlaxoSmithKline c…